Pharmaceuticals


CRD NEXT

Ultimate treatment of CRD and related infections.

Active Substances

Each g contains: erythromycin thiocyanate 50.000 U, neomycin sulfate 20.000 IU, spiramycin adipate 100.000 IU.

Description

Indicated for the treatment of mycoplasmosis, CRD, infectious synovitis, infectious arthritis, coryza, infectious synovitis, fowl cholera, pullorosis, streptococcal and staphylococcal infections, treatment of colibacillosis, salmonellosis, nonspecific diarrhoea.

Usage

Indicated for the treatment of mycoplasmosis, CRD, infectious synovitis, infectious arthritis, coryza, infectious synovitis, fowl cholera, pullorosis, streptococcal and staphylococcal infections, treatment of colibacillosis, salmonellosis, nonspecific diarrhoea.

Target Species

Poultry.

Dosage

For oral use in drinking water.

Poultry: 1 kg/1000-2000 litres of drinking water, daily, for 3-5 days.

Withdrawal Period

Poultry: meat and offal: 5 days. Eggs: 14 days.

{{brizy_dc_image_alt imageSrc=

Check other products by category

Pharmaceuticals

Supplements

Injectables

Feed Additives

Intramammary

Disinfectants